At CTA event, federal officials outline AI ambitions as clinicians debate risks
Federal healthcare agencies are accelerating efforts to expand artificial intelligence's role in healthcare, with clinical AI emerging as a top strategic priority for the Centers for Medicare & Medicaid Services.
Federal healthcare agencies are ramping up efforts to integrate artificial intelligence (AI) into clinical care, with the Centers for Medicare & Medicaid Services (CMS) designating AI as a top priority. At a healthcare AI event in Washington, D.C., Stephanie Carlton, deputy administrator at CMS and chief clinical AI officer, outlined the agency's evolving AI strategy.
CMS is focusing on four key pillars: building public trust, increasing data sharing and interoperability, establishing pathways for AI market access and regulation, and developing reimbursement frameworks for AI-enabled technologies.
The agency's flagship AI program, the ACCESS model, aims to use AI to manage chronic conditions and scale to large patient populations. Though details on future updates were not provided, CMS plans to expand the model and explore additional tracks for engagement. CMS is also considering regulatory approaches and reimbursement frameworks, particularly for higher-risk AI applications.
The ACCESS model, which accepted over 150 healthcare organizations for its launch, will provide predictable, recurring, outcomes-based payments for technology used in treating conditions like diabetes, hypertension, and depression.
Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
